Li W - Search Results

1

Genetically Engineered Liposome-like Nanovesicles as Active Targeted Transport Platform.

Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, Zhang Y, Li W, Zhang X, Chen X, Liu G. Zhang P, et al. Among authors: li w. Adv Mater. 2018 Feb;30(7). doi: 10.1002/adma.201705350. Epub 2017 Dec 27. Adv Mater. 2018. PMID: 29280210

2

Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy.

Cai W, Gao H, Chu C, Wang X, Wang J, Zhang P, Lin G, Li W, Liu G, Chen X. Cai W, et al. Among authors: li w. ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2040-2051. doi: 10.1021/acsami.6b11579. Epub 2017 Jan 11. ACS Appl Mater Interfaces. 2017. PMID: 28032505

3

Self-Assembled Metal-Organic Nanoparticles for Multimodal Imaging-Guided Photothermal Therapy of Hepatocellular Carcinoma.

Shi Z, Chu C, Zhang Y, Su Z, Lin H, Pang X, Wang X, Liu G, Li W. Shi Z, et al. Among authors: li w. J Biomed Nanotechnol. 2018 Nov 1;14(11):1934-1943. doi: 10.1166/jbn.2018.2636. J Biomed Nanotechnol. 2018. PMID: 30165929

4

Bio-engineered cell membrane nanovesicles as precision theranostics for perihilar cholangiocarcinoma.

Zhang X, Zhang Y, Zhang Y, Lv P, Zhang P, Chu C, Mao J, Wang X, Li W, Liu G. Zhang X, et al. Among authors: li w. Biomater Sci. 2020 Mar 17;8(6):1575-1579. doi: 10.1039/c9bm02088h. Biomater Sci. 2020. PMID: 32096499

5

Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.

Chen Q, Li W, Wan Y, Xia X, Wu Q, Chen Y, Lai Z, Yu C, Li W. Chen Q, et al. Among authors: li w. Hepatology. 2012 Jun;55(6):1820-9. doi: 10.1002/hep.25549. Epub 2012 Apr 25. Hepatology. 2012. PMID: 22213475

6

E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.

Li M, Ouyang L, Zheng Z, Xiang D, Ti A, Li L, Dan Y, Yu C, Li W. Li M, et al. Among authors: li w, li l. Oncol Rep. 2017 Mar;37(3):1627-1636. doi: 10.3892/or.2017.5432. Epub 2017 Feb 7. Oncol Rep. 2017. PMID: 28184929

7

Bio-engineered nano-vesicles for IR820 delivery: a therapy platform for cancer by surgery and photothermal therapy.

Zhang X, Zhou C, Wu F, Gao C, Liu Q, Lv P, Li M, Huang L, Wu T, Li W. Zhang X, et al. Among authors: li w, li m. Nanoscale. 2022 Feb 17;14(7):2780-2792. doi: 10.1039/d1nr05601h. Nanoscale. 2022. PMID: 35119448

8

Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.

Li M, Deng Y, Zhuo M, Zhou H, Kong X, Xia X, Su Z, Chen Q, Guo P, Mo P, Yu C, Li W. Li M, et al. Among authors: li w. Theranostics. 2020 Jul 11;10(19):8863-8879. doi: 10.7150/thno.45581. eCollection 2020. Theranostics. 2020. PMID: 32754284 Free PMC article.

9

Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.

Tong Z, Li M, Wang W, Mo P, Yu L, Liu K, Ren W, Li W, Zhang H, Xu J, Yu C. Tong Z, et al. Among authors: li w, li m. J Biol Chem. 2015 Jul 24;290(30):18596-608. doi: 10.1074/jbc.M115.640490. Epub 2015 Jun 16. J Biol Chem. 2015. PMID: 26082485 Free PMC article.

10

Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression.

Deng Y, Li M, Zhuo M, Guo P, Chen Q, Mo P, Li W, Yu C. Deng Y, et al. Among authors: li w, li m. J Biol Chem. 2021 Jan-Jun;296:100121. doi: 10.1074/jbc.RA120.015335. Epub 2020 Dec 3. J Biol Chem. 2021. PMID: 33434575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,012 results

Search Page

Filters